Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
Abstract Specific pathogenic mutations associated with breast cancer development can vary between ethnical groups. One example is BRCA1 c.5266dupC that was first described as a founder mutation in the Ashkenazi Jewish population, but was later also found in other populations. In Brazil, this mutation corresponds to 20% of pathogenic BRCA1 variants reported. Our objective was to investigate the haplotype component of a group of Brazilian families who inherited c.5266dupC in the BRCA1 gene and to verify the ancestry contribution from European, African, and Amerindian origins. Fourteen probands carrying c.5266dupC and 16 relatives (carriers and non-carriers) were investigated. The same haplotype was observed segregating within all the families analyzed, revealing no recombinants in a region of 0.68 Mb. Ancestry analysis demonstrated that the European component was predominant among probands. The BRCA1 c.5266dupC analysis indicates that there was a founder effect in the Brazilian population.
Main Authors: | Gomes,Renan, Soares,Barbara Luisa, Felicio,Paula Silva, Michelli,Rodrigo, Netto,Cristina B. O., Alemar,Barbara, Ashton-Prolla,Patrícia, Palmero,Edenir Inêz, Moreira,Miguel Ângelo Martins |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Genética
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000400106 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ewald,Ingrid Petroni, et al.
Published: (2016) -
Genomic rearrangements in BRCA1 and BRCA2: a literature review
by: Ewald,Ingrid Petroni, et al.
Published: (2009) -
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
by: Macedo,Gabriel S., et al.
Published: (2019) -
Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
by: Palmero,Edenir Inêz, et al.
Published: (2016) -
Hereditary non-polipomatous colorectal cancer: hereditary predisposition, diagnosis and prevention
by: Coura,Renata dos Santos, et al.
Published: (2005)